GNI Group

Since its founding in 2001, Gene Network Inc. (GNI) has been focused on new drug discovery through internal research and development, as well as the cooperation with other companies, by conducting an integrated set of business operations ranging from the search for new drugs to their clinical development, manufacture, and sales.In 2014, our company delivered Etuary to Idiopathic Pulmonary Fibrosis patients in China as the only approved therapy.'Craftmanship' is the long-lasting enterprise culture of GNI Group, which has been motivating every member of GNI to pursue perfection in proudction, and to provide best products to the world.

Supplier of technical service in China

Shanghai Genomics Technology, Ltd. is wholly-owned subsidiaries of GNI Group. Based on our mature platforms and technology advantages, we provide global first-class products and biotechnical services for researchers of life sciences, espacially for those who are interested in gene function and signaling pathway.